A study of the efficacy and cost-effectiveness of MRSA screening and monitoring on surgical wards using a new, rapid molecular test (EMMS)

BMC Health Services Research

Volumn 7, Issue , 2007, Pages

  Hardy, Katherine J ^a,b   Szczepura, Ala ^c   Davies, Ruth ^d   Bradbury, Andrew ^a   Stallard, Nigel ^c   Gossain, Savita ^a   Walley, Paul ^d   Hawkey, Peter M ^a,b  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH SERVICE; HUMAN; INFECTION CONTROL; INFECTION RATE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; SCREENING TEST; SURGICAL WARD; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; CROSS INFECTION; CROSSOVER PROCEDURE; DIAGNOSIS, MEASUREMENT AND ANALYSIS; DRUG EFFECT; ECONOMICS; EPIDEMIC; FEMALE; GENETICS; HOSPITAL SUBDIVISIONS AND COMPONENTS; ISOLATION AND PURIFICATION; MALE; MASS SCREENING; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; NOSE MUCOSA; PENICILLIN RESISTANCE; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TIME;

ADULT; AGED; COST-BENEFIT ANALYSIS; CROSS INFECTION; CROSS-OVER STUDIES; DISEASE OUTBREAKS; FEMALE; HOSPITAL UNITS; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MALE; MASS SCREENING; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NASAL MUCOSA; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TIME FACTORS;

EID: 36549049029     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-7-160     Document Type: Article

References (25)

1. Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. BS Cooper SP Stone CC Kibbler BD Cookson JA Roberts GF Medley G Duckworth R Lai S Ebrahim, BMJ 2004 329 533 15345626 10.1136/bmj.329.7465.533
2. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. EM Graffunder RA Venezia, J Antimicrob Chemother 2002 49 999 1005 10.1093/jac/dkf009 12039892
3. Deaths involving MRSA: England and Wales, 2001-2005. Health Stat Q 2007 76 81 17373385
4. Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. AC Fluit CL Wielders J Verhoef FJ Schmitz, J Clin Microbiol 2001 39 3727 3732 11574603 10.1128/JCM.39.10.3727-3732.2001
5. Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units. A Muller D Talon A Potier E Belle G Cappelier X Bertrand, Crit Care 2005 9 R246 R250 15987397 10.1186/cc3512
6. Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. R Coello J Jimenez M Garcia P Arroyo D Minguez C Fernandez F Cruzet C Gaspar, Eur J Clin Microbiol Infect Dis 1994 13 74 81 10.1007/BF02026130 8168567
7. Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). DF Brown DI Edwards PM Hawkey D Morrison GL Ridgway KJ Towner MW Wren, J Antimicrob Chemother 2005 56 1000 1018 10.1093/jac/dki372 16293678
8. Rapid detection of methicillin-resistant staphylococci from blood culture bottles by using a multiplex PCR assay. L Louie J Goodfellow P Mathieu A Glatt M Louie AE Simor, J Clin Microbiol 2002 40 2786 2790 12149330 10.1128/JCM.40.8.2786-2790.2002
9. Evaluation of the mecA femB duplex polymerase chain reaction for detection of methicillin-resistant Staphylococcus aureus. D Jonas H Grundmann D Hartung FD Daschner KJ Towner, Eur J Clin Microbiol Infect Dis 1999 18 643 647 10.1007/s100960050365 10534186
10. Detection of methicillin-resistant Staphylococcus aureus (MRSA) in blood with the EVIGENE MRSA detection kit. K Levi KJ Towner, J Clin Microbiol 2003 41 3890 3892 12904411 10.1128/JCM.41.8.3890-3892.2003
11. New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci. A Huletsky R Giroux V Rossbach M Gagnon M Vaillancourt M Bernier F Gagnon K Truchon M Bastien FJ Picard A van Belkum M Ouellette PH Roy MG Bergeron, J Clin Microbiol 2004 42 1875 1884 15131143 10.1128/JCM.42.5.1875- 1884.2004
12. Identification of methicillin-resistant Staphylococcus aureus carriage in less than 1 hour during a hospital surveillance program. A Huletsky P Lebel FJ Picard M Bernier M Gagnon N Boucher MG Bergeron, Clin Infect Dis 2005 40 976 981 10.1086/428579 15824989
13. Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. BS Cooper SP Stone CC Kibbler BD Cookson JA Roberts GF Medley GJ Duckworth R Lai S Ebrahim, Health Technol Assess 2003 7 1 194 14636487
14. Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: a 10-year survey. M Vriens H Blok A Fluit A Troelstra WC Van Der J Verhoef, Eur J Clin Microbiol Infect Dis 2002 21 782 786 10.1007/s10096-002-0811-4 12461587
15. The population impact of MRSA in a country: the national survey of MRSA in Wales, 1997. M Morgan D Evans-Williams R Salmon I Hosein DN Looker A Howard, J Hosp Infect 2000 44 227 239 10.1053/jhin.1999.0695 10706807
16. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. E Girou G Pujade P Legrand F Cizeau C Brun-Buisson, Clin Infect Dis 1998 27 543 550 9770155
17. Community-associated meticillin-resistant Staphylococcus aureus: nosocomial transmission in a neonatal unit. MD David AM Kearns S Gossain M Ganner A Holmes, J Hosp Infect 2006 64 244 250 10.1016/j.jhin.2006.06.022 16928408
18. Evaluation of three chromogenic media (MRSA-ID, MRSA-Select and CHROMagar MRSA) and ORSAB for surveillance cultures of methicillin-resistant Staphylococcus aureus. I Nahimana P Francioli DS Blanc, Clin Microbiol Infect 2006 12 1168 1174 10.1111/j.1469-0691.2006.01534.x 17121622
19. BSAC Method for antimicrobial susceptibility testing. JM Andrews, Journal of Antimicrobial Chemotherapy 2007
20. Distribution and characterization of staphylococcal interspersed repeat units (SIRUs) and potential use for strain differentiation. KJ Hardy DW Ussery BA Oppenheim PM Hawkey, Microbiology 2004 150 4045 4052 10.1099/mic.0.27413-0 15583157
21. Unit costs of health and social care. A Netten J Dennett, Personal Social Services Research Unit, University of Kent at Centerbury 1996 www.pssru.ac.uk
22. Methods for the economic evaluation of health care programmes. MF Drummond GL Stoddart GW Torrance, Oxford University Press, Oxford, U K 1990
23. Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing. MC Bootsma O Diekmann MJ Bonten, Proc Natl Acad Sci U S A 2006 103 5620 5625 16565219 10.1073/pnas.0510077103
24. Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. R Coello JR Glynn C Gaspar JJ Picazo J Fereres, J Hosp Infect 1997 37 39 46 10.1016/S0195-6701(97)90071-2 9321727
25. Effect on MRSA transmission of rapid PCR testing of patients admitted to critical care. R Cunningham P Jenks J Northwood M Wallis S Ferguson S Hunt, J Hosp Infect 2007 65 24 28 10.1016/j.jhin.2006.09.019 17145100